Home » World » Many are worried about India “rushing” to approve the self-developed COVID vaccine.

Many are worried about India “rushing” to approve the self-developed COVID vaccine.


Many parties worried about India “accelerating” approval of the self-developed COVID vaccine – BBC Thailand

Experts expressed concern over the Indian authorities. Urgently approves COVID-19 vaccine Developed in the country Before there is a complete trial of every step

On Jan. 3, the Indian government approved a vaccine, called Covaxin, a self-developed vaccine. With approval of the Oxford-AstraZeneca vaccine Developed by the University of Oxford And is being manufactured in India as well

While Prime Minister Narendra Modi sees the approval of the vaccine as a “game-changer”, many health experts warn the authorities are too hasty to approve it.

All India Drug Action Network, a health surveillance network It said the group was “shocked” and “deeply concerned about the lack of information on the vaccine’s effectiveness”, as well as the transparency that would have resulted in a lack of information on vaccine effectiveness. “It raises more questions than answers and is likely to lead to a lack of confidence in our scientific decision-makers.”

Health surveillance network This statement was issued after VJ Somani, the general director of the Indian pharmaceuticals regulator. Insist that cattle vaccine “It is safe and helps to strengthen the immune system”

He added that the vaccine was approved for limited use. “For the public good As a precaution During the period of clinical trials To give people more options for vaccination Especially in the case of a mutated infection “

“The vaccine is 100% safe,” he said, and that side effects like “mild fever, aches and allergies are common with all vaccines.”

However, the All India network of action Express concern and “I was confused by scientific reasons” for endorsing “an unfinished vaccine” and that the hypothesis that it may be useful to inhibit viral mutations was not supported by experimental data.

Dr. Kagandeep Kang, one of India’s most famous medical experts. She told the Times of India that she “had never seen anything like this before” and did not see “any information presented or published on the effectiveness of this vaccine”.

Even many social media users commented that Approval of the vaccine before the trial is complete is a concern. Not including the matter that After all, how safe or effective is this vaccine?

…………….

A matter of reliability

Vikas Panday, BBC News, New Delhi

Many opposition scientists and politicians have raised the question of what they call the “humanitarianism”. It is urgent to certify cattle vaccines produced by Indian pharmaceutical company Bharat Biotech.

The company developed the vaccine in collaboration with the Indian Council of Medical Research. And this effort is regarded as It is an example of India’s greatness in vaccine production and development.

The governing body states that The vaccine is safe and it works. The company stated that The experiments of stage 1 and 2 worked very well.

But the scientist Instead, the government’s decision to not disclose the effectiveness of the vaccine to be examined was a concern.

Prime Minister Modi Rejoice at the certification of this vaccine and pointed out that The cattle vaccine is a vivid example of his efforts to make India as self-sufficient as possible.

But many experts are concerned that the lingering question of the vaccine approval process poses problems. Many people still want to see the transparency of the process. Because of the success of the COVID-19 vaccine program It depends on the trust of the people.

………………..

The urgent approval of the vaccine also sparked a furious response on Twitter on Sunday night between India’s ministers and opposition leaders.

Indian Health Minister Dr Harshwardon said opposition leaders They “don’t appreciate the nation’s ability to produce vaccines”. But many members of the main opposition Congress party Including former Chief Minister of Uttar Pradesh They expressed their concern.

………………..

……………..

The certification of the vaccine comes as India is rushing to vaccinate more than 1.3 billion of its own people. Amid the worries that Richer countries are buying massive amounts of vaccines. It looks like India is hoarding the vaccine as well.

In an interview with AP News, Adar Punavalla, director of the Indian Institute of Serum Serums. The institute is currently producing a vaccine developed by Oxford-AstraZeneca, saying the vaccine was urgently certified on the condition that it would not be exported outside India.

India plans to vaccinate some 300 million people on the list of first-line vaccines by August.

India has number of cases of COVID-19. Second highest in the world With more than 10.3 million confirmed cases and nearly 150,000 deaths.

Both vaccines were approved on Sunday. Can be transported and stored at normal refrigerated temperature.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.